Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze ABEO stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ABEO investment potential.

What is ABEO stock price today?

Get real-time ABEO stock price, historical data, and price charts on Financhill. Track ABEO performance with our advanced analysis tools.

Is ABEO a good investment?

Evaluate ABEO investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ABEO stock?

To buy ABEO stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ABEO?

View detailed market capitalization data and company valuation metrics for ABEO on our comprehensive analysis page.

What is the P/E ratio of ABEO?

Use our fundamental analysis tools to view ABEO P/E ratio and compare valuation metrics with industry peers.

What are ABEO earnings?

View ABEO earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Abeona Therapeutics, Inc. 10K Form

Buy

ABEO
Abeona Therapeutics, Inc.

Last Price:

$5.42

Seasonality Move:

17.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-13	10Q	ABEO/Abeona Therapeutics, Inc. Quarterly
2023-08-08	10Q	ABEO/Abeona Therapeutics, Inc. Quarterly
2023-05-11	10Q	ABEO/Abeona Therapeutics, Inc. Quarterly
2022-11-14	10Q	ABEO/Abeona Therapeutics, Inc. Quarterly
2022-08-11	10Q	ABEO/Abeona Therapeutics, Inc. Quarterly
2022-05-13	10Q	ABEO/Abeona Therapeutics, Inc. Quarterly

Receive ABEO News And Ratings

See the #1 stock for the next 7 days that we like better than ABEO

ABEO Financial Statistics

Sales & Book Value

Annual Sales:	$0
Cash Flow:	$-23.7M
Price / Cash Flow:	0
Annual Sales:	$3.27
Price / Book:	1.72

Profitability

EPS (TTM):	1.16530
Net Income (TTM):	$82.4M
Gross Margin:	$-2.9M
Return on Equity:	88.36%
Return on Assets:	51.07%

Abeona Therapeutics, Inc. Earnings Forecast

Key Abeona Therapeutics, Inc. Financial Ratios

Per Share Earnings over the last 30 years have been positive in 18 years.

Abeona Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	ABEO
CUSIP:	00289Y
Website:	abeonatherapeutics.com

Debt

Debt-to-Equity Ratio:	0.14
Current Ratio:	9.74
Quick Ratio:	9.35

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	1158

ABEO Technical Analysis vs Fundamental Analysis

Buy

Abeona Therapeutics, Inc. (ABEO) is a Buy

Is Abeona Therapeutics, Inc. a Buy or a Sell?

Abeona Therapeutics, Inc. stock is rated a Buy

The current Abeona Therapeutics, Inc. [ABEO] share price is $5.41. The Score for ABEO is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.